Breye Therapeutics is a Danish-based biopharmaceutical firm founded in 2015. The company is currently in the clinical stages and focuses on providing cutting-edge oral treatments for the management of retinal vascular diseases. Its recent milestone includes securing a significant €4.00MSeed Round investment on 10 November 2022. The investors involved in this round were Novo Holdings and Sound Bioventures.
Breye Therapeutics
A Danish-based biopharmaceutical firm in the clinical stages, is working to provide advanced oral treatments for the management of retinal vascular diseases
Founded 2015
Series A
Total: $71.50M
Biopharma
General Information
Company Name
Breye Therapeutics
Founded Year
2015
Industries
Biopharma
Funding Stage
Series A
Social
BounceWatch is an independent company data service, not affiliated with Breye Therapeutics. To contact Breye Therapeutics, visit breyetx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Breye Therapeutics compare?
A PDF of Breye Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Breye Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Breye Therapeutics on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.
In The News
Oct 16, 2026
Featured on Eu-startups: Oxford spin-out OMass Therapeutics lands €275 million to bring novel small-molec...
About Breye Therapeutics
Business keywords: biopharmaceutical, clinical stages, oral treatments, retinal vascular diseases, biotech, medical research, clinical trials, drug development
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | €67.50M | 9 |
|
02 Oct 2026 |
| Pre Seed Round | Undisclosed | 3 |
|
10 Nov 2022 |
| Seed Round | €4.00M | 2 |
|
10 Nov 2022 |
Latest News
View All
Breye Therapeutics Alternatives & Competitors
View All Alternatives
Breye Therapeutics vs
Antharis Therapeutics, Inc.
United States
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting-edge trea...
18 employees
Biopharma, Biotechnology
Breye Therapeutics vs
Antios Therapeutics
United States
Antios Therapeutics is a clinical-stage biopharmaceutical company devoted to developing therapies fo...
1 employees
Biopharma, Biotechnology
Breye Therapeutics vs
San Francisco Bay-based clinical stage biopharmaceutical company dedicated to pioneering novel treat...
Series B
11-50 employees
Biopharma, Biotechnology
FAQ About Breye Therapeutics
A Danish-based biopharmaceutical firm in the clinical stages, is working to provide advanced oral treatments for the management of retinal vascular diseases
Breye Therapeutics was founded in 2015.
Breye Therapeutics operates in Biopharma. Its work centres on biopharmaceutical, clinical stages, oral treatments and retinal vascular diseases.
Breye Therapeutics has completed 3 funding rounds, raising a total of $71.50M. The latest funding stage is Series A.
Top alternatives and competitors to Breye Therapeutics include Antharis Therapeutics, Inc., Antios Therapeutics, Armetheon, Kinarus Therapeutics, KeifeRx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Breye Therapeutics and Antharis Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Breye Therapeutics, https://bouncewatch.com/company/breye-therapeutics, updated 2 October 2026. When citing, please name BounceWatch and link this page.
